1-20 of 37
Ronan Foley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Healthcare Resource Utilization Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study

Alissa Visram, Hsien Seow, Gregory Pond, Ana Gayowsky, Arleigh McCurdy, Christopher Cipkar, Hyra Sapru, C. Tom Kouroukis, Mohammed Aljama, Mohammad Ebraheem, Stephen Ronan Foley, Hira Mian
Journal: Blood
Blood (2023) 142 (Supplement 1): 3774.
https://doi.org/10.1182/blood-2023-190426
Published: 2023
Journal Articles

LSD1 Inhibition Synergizes with Venetoclax in Acute Myeloid Leukemia By Targeting Cellular Metabolism

Kanwaldeep Singh, Emily Hartung, Christina Muhs, Islam Alshamleh, Monisha Divakaran, Anna Dvorkin-Gheva, Sara Pishyar, Pradhariny Prabagaran, Dina Khalaf, Alejandro Garcia-Horton, Stephen Ronan Foley, Brian Leber, Irwin Walker, Kylie Lepic, Harald Schwalbe, Hubert Serve, Maria Kleppe, Hugh Young Rienhoff, Jr., Tobias Berg
Journal: Blood
Blood (2023) 142 (Supplement 1): 4156.
https://doi.org/10.1182/blood-2023-189515
Published: 2023
Journal Articles

Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting

Daniel J. Landsburg, Michael Heim, Amy Moskop, Stephen Ronan Foley, Brian T. Hill, Grant Schofield, Caron Jacobson, Samantha M. Jaglowski, Frederick L. Locke, Ron Ram, Peter A Riedell, Gunjan L. Shah, Leslie L. Popplewell, Ranjan Tiwari, Stephen Lim, Harald Jakob Maier, Marta Majdan, Marcelo Pasquini, Matthew J Frigault
Journal: Blood
Blood (2023) 142 (Supplement 1): 3496.
https://doi.org/10.1182/blood-2023-179387
Published: 2023
Journal Articles

Real-World Tisagenlecleucel Outcomes in Richter-Transformed Chronic Lymphocytic Leukemia: A Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis

Mazyar Shadman, Matthew J Frigault, Stephen Ronan Foley, Brian T. Hill, Grant Schofield, Caron Jacobson, Samantha M. Jaglowski, Frederick L. Locke, Daniel J. Landsburg, Ron Ram, Peter A Riedell, Gunjan L. Shah, Leslie L. Popplewell, Ranjan Tiwari, Stephen Lim, Harald Jakob Maier, Marta Majdan, Marcelo Pasquini
Journal: Blood
Blood (2023) 142 (Supplement 1): 3497.
https://doi.org/10.1182/blood-2023-180233
Published: 2023
Journal Articles

Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphomas

Amaris K. Balitsky, Gregory R Pond, Graeme Fraser, Tom Kouroukis, Stephen Ronan Foley
Journal: Blood
Blood (2022) 140 (Supplement 1): 8036–8037.
https://doi.org/10.1182/blood-2022-165674
Published: 2022
Journal Articles

Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Daniel J. Landsburg, Matthew Frigault, Michael Heim, Stephen Ronan Foley, Brian T. Hill, Christine M. Ho, Caron A. Jacobson, Samantha Jaglowski, Frederick L. Locke, Ron Ram, Peter A. Riedell, Gunjan L. Shah, Leslie L. Popplewell, Ranjan Tiwari, Stephen Lim, Marta Majdan, Aisha Masood, Marcelo C Pasquini, Cameron J. Turtle
Journal: Blood
Blood (2022) 140 (Supplement 1): 1584–1587.
https://doi.org/10.1182/blood-2022-158822
Published: 2022
Journal Articles

Real-World Efficacy and Safety Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Daniel J Landsburg, Matthew J. Frigault, Zhen-Huan Hu, Samantha Jaglowski, Frederick L. Locke, Christine Ho, Miguel-Angel Perales, Caron Jacobson, Brian T. Hill, Stephen Ronan Foley, Peter A. Riedell, Ranjan Tiwari, Aisha Masood, Stephen Lim, Marta Majdan, Marcelo C Pasquini, Cameron J. Turtle
Journal: Blood
Blood (2021) 138 (Supplement 1): 429.
https://doi.org/10.1182/blood-2021-146397
Published: 2021
Journal Articles

Novel Single Panel Method for Minimal Residual Disease Detection for Plasma Cells By Flow Cytometry

David Kimmel, BSc,Mlt, Mohammed A Aljama, MBBS,FRCPC, Stephen Ronan Foley, MD FRCPC, Hira S Mian, MD, Catherine A Ross, MD MSc ,FRCPC
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-141060
Published: 2020
Journal Articles

Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel

Charalambos Andreadis, MD MSCE, Constantine S. Tam, MBBS, MD, Peter Borchmann, MD PhD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Harald Holte, MD PhD, Edmund K. Waller, PhDMD, Samantha Jaglowski, MDMPH, Michael R. Bishop, MD, Stephen Ronan Foley, MD FRCPC, Jason R. Westin, MD, Isabelle Fleury, MD, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), Stephan Mielke, MD, Takanori Teshima, MD, Gilles A. Salles, MD PhD, Stephen J Schuster, MD, Veronika Bachanova, MD PhD, Richard T. Maziarz, MD, Koen Van Besien, MD PhD, Koji Izutsu, MD PhD, John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Paolo Corradini, Ranjan Tiwari, MSc, Rakesh Awasthi, PhD, Tomasz Lawniczek, MD, Lamis K. Eldjerou, MD, Marie Jose Kersten, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2883.
https://doi.org/10.1182/blood-2019-124492
Published: 2019
Journal Articles

Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)

Veronika Bachanova, MD PhD, Constantine S. Tam, MBBS, MD, Peter Borchmann, MD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Harald Holte, MD PhD, Edmund K. Waller, PhDMD, Samantha Jaglowski, MDMPH, Michael R. Bishop, MD, Charalambos Andreadis, MD MSCE, Stephen Ronan Foley, MD FRCPC, Jason R. Westin, MD, Isabelle Fleury, MD, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), Stephan Mielke, MD, Takanori Teshima, MD, Gilles Salles, MD PhD, Stephen J Schuster, MD, Richard T. Maziarz, MD, Koen Van Besien, MD PhD, Koji Izutsu, MD PhD, Marie Jose Kersten, MD PhD, John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Paolo Corradini, Jufen Chu, PhD, Irina Gershgorin, PhD, Therese Choquette, PhD, Lida Bubuteishvili Pacaud, MD, Margit Jeschke, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 242.
https://doi.org/10.1182/blood-2019-128302
Published: 2019
Journal Articles

Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial

Jason R. Westin, MD, Constantine S. Tam, MBBS, MD, Peter Borchmann, MD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Harald Holte, MD PhD, Edmund K. Waller, PhDMD, Samantha Jaglowski, MDMPH, Michael R. Bishop, MD, Charalambos Andreadis, MD MSCE, Stephen Ronan Foley, MD FRCPC, Isabelle Fleury, MD, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), Stephan Mielke, MD, Takanori Teshima, MD, Stephen J Schuster, MD, Veronika Bachanova, MD PhD, Richard T. Maziarz, MD, Koen Van Besien, MD PhD, Koji Izutsu, MD PhD, Marie Jose Kersten, MD PhD, John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Paolo Corradini, Xia Han, MS, Ranjan Tiwari, MSc, Sergei Agoulnik, PhD, Lamis K. Eldjerou, MD, Lida Bubuteishvili Pacaud, MD, Gilles A. Salles, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4103.
https://doi.org/10.1182/blood-2019-129107
Published: 2019
Journal Articles

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Jean Roy, MD, Tony Panzarella, M.Sc., P.Stat, Stephen Couban, MDBSc, Félix Couture, MD FRCPC, Gerald M. Devins, PhD, Mohamed Elemary, MD, Stephen Ronan Foley, MD FRCPC, Genevieve Gallagher, MD, John Kuruvilla, MD, Stephanie J. Lee, MD MPH, John Moore, MDFRACP,FRCPA, Thomas J Nevill, MD, Gizelle Popradi, MD FRCP, Kirk R. Schultz, MD, David Szwajcer, MD FRCPC, Cynthia L Toze, MD FRCPC, Irwin Walker, MBBS, FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 875.
https://doi.org/10.1182/blood-2019-123275
Published: 2019
Journal Articles

Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel

Stephen J. Schuster, MD, Michael R. Bishop, MD, Constantine Tam, MD PhD, Peter Borchmann, MD, Ulrich Jaeger, MD, Edmund K. Waller, MD, Harald Holte, MD PhD, Joseph P. McGuirk, DO, Samantha Jaglowski, MDMPH, Kensei Tobinai, MD PhD, Charalambos Andreadis, MD MSCE, Isabelle Fleury, Stephan Mielke, MD, Takanori Teshima, Jason R. Westin, MD, Veronika Bachanova, MD PhD, Stephen Ronan Foley, MD FRCPC, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Marie Jose Kersten, MD PhD, Koen Van Besien, MD PhD, Jufen Chu, PhD, Aline Jary, MS, Özlem Anak, MD, Gilles Salles, MD PhD, Richard Thomas T. Maziarz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1684.
https://doi.org/10.1182/blood-2018-99-115252
Published: 2018
Journal Articles

Plerixafor effectively mobilizes CD56 bright NK cells in blood, providing an allograft predicted to protect against GVHD

Peggy P. C. Wong, Amina Kariminia, David Jones, Connie J. Eaves, Ronan Foley, Sabine Ivison, Stephen Couban, Kirk R. Schultz
Journal: Blood
Blood (2018) 131 (25): 2863–2866.
https://doi.org/10.1182/blood-2018-03-836700
Published: 2018
Journal Articles

Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

Rakesh Awasthi, PhD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ulrich Jaeger, MD, Samantha Jaglowski, MD MPH, Stephen Ronan Foley, MD FRCPC, Koen Van Besien, MD PhD, Nina D. Wagner-Johnston, MD, Marie Jose Kersten, MD PhD, Stephen J. Schuster, MD, Gilles Andre Salles, MD PhD, Richard Thomas Maziarz, MD, Oezlem Anak, MD, Lida Bubuteishvili Pacaud, MD, Lucien Gazi, PhD, Edward Waldron, PhD, Jason Hamilton, PhD, Iulian Pruteanu, PhD, Feng Tai, PhD, Karen Thudium Mueller, PharmD,MSc, Edmund K. Waller, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5211.
https://doi.org/10.1182/blood.V130.Suppl_1.5211.5211
Published: 2017
Journal Articles

Patient-Reported Quality of Life (QoL) Following CTL019 Infusion in Adult Patients (pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

Richard Thomas Maziarz, MD, Michael R. Bishop, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Peter Borchmann, MD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Edmund K. Waller, MD, Samantha Jaglowski, MD, Charalambos Andreadis, MD MSCE, Stephen Ronan Foley, MD FRCPC, Isabelle Fleury, MD MSc, FRCP, Stephan Mielke, MD, Jason R. Westin, MD, Phoebe Joy Ho, Veronika Bachanova, MD PhD, Harald Holte, John M. Magenau, MD, Oezlem Anak, MD, Lida Bubuteishvili Pacaud, MD, Siegbert Guenther, Jie Zhang, PhD, Lawrence Rasouliyan, MPH, Feng Tai, PhD, Gilles Salles, MD PhD, Stephen J. Schuster, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5215.
https://doi.org/10.1182/blood.V130.Suppl_1.5215.5215
Published: 2017
Journal Articles

Primary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster, MD, Michael R. Bishop, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Edmund K. Waller, MD, Peter Borchmann, MD, Joseph P. McGuirk, DO, Ulrich Jaeger, MD, Samantha Jaglowski, MD, Charalambos Andreadis, MD MSCE, Jason R. Westin, MD, Isabelle Fleury, MD MSc, FRCPC, Veronika Bachanova, MD PhD, Stephen Ronan Foley, MD FRCPC, P. Joy Ho, MBBS, DPhil, FRACP, FRCPA, FFSc(RCPA), Stephan Mielke, MD, John M. Magenau, MD, Harald Holte, Koen Van Besien, MD PhD, Marie Jose Kersten, MD PhD, Takanori Teshima, MD PhD, Kensei Tobinai, MD PhD, Paolo Corradini, MD, Oezlem Anak, MD, Lida Bubuteishvili Pacaud, MD, Christopher del Corral, PharmaD, Rakesh Awasthi, PhD, Feng Tai, PhD, Gilles Salles, MD PhD, Richard Thomas Maziarz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 577.
https://doi.org/10.1182/blood.V130.Suppl_1.577.577
Published: 2017
Journal Articles

Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma

Hira Mian, Theodore E. Warkentin, Jo-Ann I. Sheppard, Anna MacDonald, Lori-Ann Linkins, Ann Benger, Ronan Foley
Journal: Blood
Blood (2017) 130 (14): 1679–1682.
https://doi.org/10.1182/blood-2017-06-788679
Published: 2017
Journal Articles

Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Improve Event-Free Survival (GRFS) and Overall Survival in a T-Cell Depleted Haploidentical HSCT: Phase 2 Trial in Patients with AML and ALL

Denis-Claude Roy, MD, Silvy Lachance, MD, Jean Roy, MD, Irwin Walker, MBBS, Johan Maertens, MD PhD, Jean-Sebastien Delisle, MD PhD, Stephen Ronan Foley, MD, Philippe Lewalle, MDPhD, Eduardo Olavarria, Dominik Selleslag, MD, Manfred Rüdiger, PhD, Jurjen Velthuis, PhD, Lisya Gerez, Jeroen Rovers, MD PhD, Halvard Bonig, MD MA, Stephan Mielke, MD
Journal: Blood
Blood (2016) 128 (22): 1226.
https://doi.org/10.1182/blood.V128.22.1226.1226
Published: 2016
Journal Articles

Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Reduce Transplant Related Mortality and Improve Overall Survival in Haploidentical HSCT for Patients with AML and ALL, Using an Immunosuppressant-Free Transplant Regimen

Denis-Claude Roy, MD, Silvy Lachance, MD, Jean Roy, MD, Irwin Walker, MBBS, Johan Maertens, MD PhD, Sandra Cohen, MD, Stephen Ronan Foley, MD, Philippe Lewalle, MD PhD, Eduardo Olavarria, MD PhD, Dominik Selleslag, MD, Manfred Rudiger, Jurjen Velthuis, PhD, Karen Reitsma, PhD, Lisya Gerez, Jeroen Rovers, MDPhD, Halvard Bonig, MD MA, Stephan Mielke, MD
Journal: Blood
Blood (2015) 126 (23): 4391.
https://doi.org/10.1182/blood.V126.23.4391.4391
Published: 2015